2026 ICD-10-CM Diagnosis Code C50.A2Malignant inflammatory neoplasm of left breast
C50.A2 is a billable ICD-10-CM diagnosis code for malignant inflammatory neoplasm of left breast. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026) and groups to MS-DRG 582 through 583, 597 through 599.
Code Identity
Code Classification
Table of NeoplasmsClinical
Anatomical sites in the Table of Neoplasms that reference this code family.
| Site | Malig. Primary | Malig. Secondary | Ca in situ | Benign | Uncertain | Unspec. |
|---|---|---|---|---|---|---|
| breast (connective tissue) (glandular tissue) (soft parts) › inflammatory | C50.A | – | – | – | – | – |
Code History & ChangesHistory
New Code C50.A2 was added to the ICD-10-CM code set for FY 2026, effective October 1, 2025.
Replacement C50.A2 replaces the following previously assigned code(s):
- C50.912 - Malignant neoplasm of unspecified site of left female breast
- C50.922 - Malignant neoplasm of unspecified site of left male breast
Questions About C50.A2Overview
Is C50.A2 (Malignant inflammatory neoplasm of breast) a billable code?
Yes. This is a billable ICD-10-CM code, specific enough to report malignant inflammatory neoplasm of left breast on HIPAA-covered claims from October 1, 2025 through September 30, 2026.
What MS-DRG does C50.A2 group to?
When malignant inflammatory neoplasm of left breast is the principal diagnosis on an inpatient stay, it groups to MS-DRG 582, 583, 597, 598, 599, with relative weights from 0.7332 to 1.9266 depending on complications. Higher weights mean higher Medicare reimbursement.
